Intelivation

Executive Summary

Intelivation Technologies is a San Francisco-based private company focused on developing AI-driven diagnostic and surgical products for orthopedics and neurosurgery. Founded in 2018, the company aims to improve clinical outcomes by providing surgeons with real-time, data-driven insights during procedures. Intelivation's platform leverages machine learning to analyze medical imaging and intraoperative data, potentially reducing complications, shortening recovery times, and enhancing surgical precision. The company operates at the intersection of digital health and AI, targeting a growing market for minimally invasive and personalized surgical care. While Intelivation has not publicly disclosed funding rounds or revenue, its focus on high-value surgical specialties positions it for strategic partnerships with hospitals and device manufacturers. Key risks include reliance on regulatory clearances (e.g., FDA 510(k)), early-stage commercialization, and competition from established players in surgical navigation and AI diagnostics. The company's success hinges on achieving product-market fit, securing reimbursement, and demonstrating clinical efficacy through peer-reviewed studies. With no disclosed milestones or pipeline, Intelivation remains a speculative opportunity, but its niche in orthopedic and neurosurgery AI diagnostics offers significant upside if execution succeeds.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for AI-Assisted Surgical Planning Software40% success
• Q2 2026Series A Funding Round50% success
• Q3 2026Strategic Partnership with a Major Hospital Network or Device Manufacturer35% success